Search

everythinglearnresearchcommunity

for

Search:↓

Ephrins slow down skin and hair follicle cell growth.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

The nutritional supplement improved hair density and reduced hair loss in women with female pattern hair loss.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Scalp melanomas are more dangerous and often missed, needing earlier detection.

Female hair loss linked to metabolic syndrome, not in males.

ALA-photodynamic therapy helps reduce acne by causing acne cell death and lowering certain skin protein levels.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Finasteride reduces prostate bleeding by affecting blood vessel growth.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

The conclusion is that measuring how drugs partition into artificial sebum is important for predicting their delivery into hair and sebaceous follicles, and it provides better information than traditional methods.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

CIP/KIP proteins help stop cell division and support hair growth.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.